Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Stock
Equities
600613
CNE000000453
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.95 CNY | +0.51% | -9.02% | -21.81% |
Sales 2021 | 2.3B 318M | Sales 2022 | 2.39B 330M | Capitalization | 4.22B 583M |
---|---|---|---|---|---|
Net income 2021 | 69M 9.53M | Net income 2022 | 48M 6.63M | EV / Sales 2021 | 1.35 x |
Net cash position 2021 | 182M 25.07M | Net cash position 2022 | 371M 51.23M | EV / Sales 2022 | 1.61 x |
P/E ratio 2021 |
49.4
x | P/E ratio 2022 |
91.4
x | Employees | 1,570 |
Yield 2021 |
1.56% | Yield 2022 |
1.22% | Free-Float | 49.01% |
1 day | -2.79% | ||
1 week | -9.48% | ||
Current month | -8.50% | ||
1 month | -12.30% | ||
3 months | -15.79% | ||
6 months | -25.35% | ||
Current year | -22.21% |
Managers | Title | Age | Since |
---|---|---|---|
Bin Feng
CEO | Chief Executive Officer | 52 | 05-06-30 |
Ke Jing Wu
SEC | Corporate Secretary | 47 | 17-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Feng
CEO | Chief Executive Officer | 52 | 05-06-30 |
Zhi Ting Zhang
BRD | Director/Board Member | 80 | 20-06-25 |
Tao Tao Zhang
CHM | Chairman | 43 | 14-06-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 5.95 | +0.51% | 4 383 605 |
24-04-18 | 5.92 | -2.79% | 6,576,300 |
24-04-17 | 6.09 | +8.17% | 7,895,100 |
24-04-16 | 5.63 | -7.10% | 8,766,132 |
24-04-15 | 6.06 | -4.42% | 8,929,099 |
End-of-day quote Shanghai S.E., April 17, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-22.21% | 425M | |
+25.59% | 672B | |
+23.92% | 550B | |
-6.44% | 351B | |
+14.74% | 317B | |
+7.00% | 292B | |
+2.96% | 211B | |
+0.33% | 203B | |
-11.20% | 144B | |
-7.75% | 141B |
- Stock Market
- Equities
- 600613 Stock